Suscribirse

Farm animal exposure, respiratory illnesses, and nasal cell gene expression - 05/06/24

Doi : 10.1016/j.jaci.2024.01.019 
Joshua Brownell, MD a, Kristine E. Lee, MS b, Deborah Chasman, PhD b, c, Ronald Gangnon, PhD b, Casper G. Bendixsen, PhD d, Katherine Barnes, MS, MPH d, Kristine Grindle, BS a, Tressa Pappas, BS a, Yury A. Bochkov, PhD a, Amy Dresen, BS a, Christine Hou, BS e, David B. Haslam, MD f, Christine M. Seroogy, MD a, Irene M. Ong, PhD b, c, James E. Gern, MD a,
a Department of Pediatrics, University of Wisconsin–Madison, Madison, Wis 
b Department of Biostatistics and Medical Informatics, University of Wisconsin–Madison, Madison, Wis 
c Department of Obstetrics and Gynecology, University of Wisconsin–Madison, Madison, Wis 
d National Farm Medicine Center, Marshfield Clinic Research Institute, Marshfield, Wis 
e Department of Statistics, University of Wisconsin–Madison, Madison 
f Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio 

Corresponding author: James E. Gern, MD, K4/918 CSC, 600 Highland Ave, Madison, WI 53792-9988.K4/918 CSC600 Highland AveMadisonWI53792-9988

Abstract

Background

Farm exposures in early life reduce the risks for childhood allergic diseases and asthma. There is less information about how farm exposures relate to respiratory illnesses and mucosal immune development.

Objective

We hypothesized that children raised in farm environments have a lower incidence of respiratory illnesses over the first 2 years of life than nonfarm children. We also analyzed whether farm exposures or respiratory illnesses were related to patterns of nasal cell gene expression.

Methods

The Wisconsin Infant Study Cohort included farm (n = 156) and nonfarm (n = 155) families with children followed to age 2 years. Parents reported prenatal farm and other environmental exposures. Illness frequency and severity were assessed using illness diaries and periodic surveys. Nasopharyngeal cell gene expression in a subset of 64 children at age 2 years was compared to farm exposure and respiratory illness history.

Results

Farm versus nonfarm children had nominally lower rates of respiratory illnesses (rate ratio 0.82 [95% CI, 0.69, 0.97]) with a stepwise reduction in illness rates in children exposed to 0, 1, or ≥2 animal species, but these trends were nonsignificant in a multivariable model. Farm exposures and preceding respiratory illnesses were positively related to nasal cell gene signatures for mononuclear cells and innate and antimicrobial responses.

Conclusions

Maternal and infant exposure to farms and farm animals was associated with nonsignificant trends for reduced respiratory illnesses. Nasal cell gene expression in a subset of children suggests that farm exposures and respiratory illnesses in early life are associated with distinct patterns of mucosal immune expression.

El texto completo de este artículo está disponible en PDF.

Key words : Farm, respiratory illness, virus, gene expression, nasal epithelial cells, children

Abbreviations used : AD, ILC2, RR, SARS-CoV-2, WISC


Esquema


© 2024  American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 153 - N° 6

P. 1647-1654 - juin 2024 Regresar al número
Artículo precedente Artículo precedente
  • A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination
  • Muhammad B. Khalid, Ellen Zektser, Eric Chu, Min Li, Joanna Utoh, Patrick Ryan, Hanna S. Loving, Roa Harb, Robbie Kattappuram, Lindsay Chatman, Stella Hartono, Estefania Claudio-Etienne, Guangping Sun, Edward P. Feener, Zhongbo Li, Samuel K. Lai, Quang Le, Lawrence B. Schwartz, Jonathan J. Lyons, Hirsh Komarow, Zhao-Hua Zhou, Haniya Raza, Maryland Pao, Karen Laky, Steven M. Holland, Erica Brittain, Pamela A. Frischmeyer-Guerrerio
| Artículo siguiente Artículo siguiente
  • Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals
  • Ottavia M. Delmonte, Cihan Oguz, Kerry Dobbs, Katherine Myint-Hpu, Boaz Palterer, Michael S. Abers, Deborah Draper, Meng Truong, Ian M. Kaplan, Rachel M. Gittelman, Yu Zhang, Lindsey B. Rosen, Andrew L. Snow, Clifton L. Dalgard, Peter D. Burbelo, Luisa Imberti, Alessandra Sottini, Eugenia Quiros-Roldan, Francesco Castelli, Camillo Rossi, Duilio Brugnoni, Andrea Biondi, Laura Rachele Bettini, Mariella D’Angio, Paolo Bonfanti, Megan V. Anderson, Annalisa Saracino, Maria Chironna, Mariantonietta Di Stefano, Jose Ramon Fiore, Teresa Santantonio, Riccardo Castagnoli, Gian Luigi Marseglia, Mary Magliocco, Marita Bosticardo, Francesca Pala, Elana Shaw, Helen Matthews, Sarah E. Weber, Sandhya Xirasagar, Jason Barnett, Andrew J. Oler, Dimana Dimitrova, Jenna R.E. Bergerson, David H. McDermott, V. Koneti Rao, Philip M. Murphy, Steven M. Holland, Andrea Lisco, Helen C. Su, Michail S. Lionakis, Jeffrey I. Cohen, Alexandra F. Freeman, Thomas M. Snyder, Justin Lack, Luigi D. Notarangelo

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.